BONDARENKO JAMIESON enters BRIACELL THERAPEUTICS CORP. with 119.86K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 8/11/2022ACC: 0001493152-22-022149
Director
Since Aug 2022
119.86K
Baseline shares
100% direct
119.86K
Direct ownership
1 position
500K
Derivative underlying
4 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Shares
DirectShares owned119.86K
Total
119.86K direct119.86K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares | 119.86K | Direct |
| Total | 119.86K | 119.86K direct |
Derivative Holdings4
Warrant
DirectUnderlying security
Common Shares
Underlying shares
30K
Shares owned
N/A
Exercise price
5.31
Expiration
—
Exercise window
—
Warrant
DirectUnderlying security
Common Shares
Underlying shares
70K
Shares owned
N/A
Exercise price
5.31
Expiration
—
Exercise window
—
Option (Right to Buy)
DirectUnderlying security
Common Shares
Underlying shares
150K
Shares owned
N/A
Exercise price
4.24
Expiration
—
Exercise window
—
Option (Right to Buy)
DirectUnderlying security
Common Shares
Underlying shares
250K
Shares owned
N/A
Exercise price
8.47
Expiration
—
Exercise window
—
Total
Underlying
500K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Warrant Direct | Common Shares | 5.31 | — | — | 30K | N/A |
| Warrant Direct | Common Shares | 5.31 | — | — | 70K | N/A |
| Option (Right to Buy) Direct | Common Shares | 4.24 | — | — | 150K | N/A |
| Option (Right to Buy) Direct | Common Shares | 8.47 | — | — | 250K | N/A |
| Total | 500K | 0.00 | ||||